Cargando…
N-acetylcysteine for the treatment of COVID-19 among hospitalized patients
Autores principales: | Avdeev, Sergey N., Gaynitdinova, Viliya V., Merzhoeva, Zamira M., Berikkhanov, Zelimkhan G.-M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The British Infection Association. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8271031/ https://www.ncbi.nlm.nih.gov/pubmed/34252497 http://dx.doi.org/10.1016/j.jinf.2021.07.003 |
Ejemplares similares
-
Asthma in older adults with severe coronavirus disease 2019: Clinical outcomes and predictors of mortality
por: Avdeev, Sergey N., et al.
Publicado: (2022) -
How can we predict the failure of awake proning in acute hypoxemic respiratory failure associated with COVID-19?
por: Avdeev, Sergey N., et al.
Publicado: (2022) -
N-acetylcystein in dengue hepatitis
por: Wiwanitkit, Viroj
Publicado: (2014) -
Recombinant tissue plasminogen activator treatment for COVID-19 associated ARDS and acute cor pulmonale
por: Kosanovic, Djuro, et al.
Publicado: (2021) -
Pain, Swelling and Blue Discoloration of Right Hand in a COVID-19 Patient
por: Avdeev, Sergey N., et al.
Publicado: (2021)